Get startedLog in
    Picture of Dr. Reddy's Laboratories logo

    DRREDDY — Dr. Reddy's Laboratories News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    India's Dr Reddy's falls on semaglutide supply delay due to API issue

    Picture of Dr. Reddy's Laboratories logoDr. Reddy's Laboratories
    09/07/2026 07:17
    BUZZ-India's Dr Reddy's falls on semaglutide supply delay due to API issue
    Updates
    ** Shares of Dr Reddy's Laboratories REDY.NS down as much as 6.5% at 1261.1 rupees 
    ** Stock marks its highest intraday pct drop since January 2025
    ** The pharmaceuticals company says commercial supply of semaglutide will be delayed due to an issue associated with the active ingredient
    ** "There is no impact on patient safety or on the product's existing global regulatory filings," REDY says
    ** YTD, REDY stock up ~0.4%

     (Reporting by Vijay Malkar)
     ((VijayDattaram.Malkar@thomsonreuters.com;))

    Recent news on Dr. Reddy's Laboratories

    See all news